Chiron Capital Management LLC trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 10.4% in the 3rd quarter, HoldingsChannel reports. The firm owned 71,084 shares of the exchange traded fund’s stock after selling 8,254 shares during the quarter. SPDR S&P Biotech ETF makes up approximately 6.1% of Chiron Capital Management LLC’s portfolio, making the stock its 2nd largest holding. Chiron Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $7,123,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also added to or reduced their stakes in the stock. Capital A Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $26,000. Johnson Financial Group Inc. bought a new position in shares of SPDR S&P Biotech ETF during the second quarter worth $31,000. Twin Peaks Wealth Advisors LLC purchased a new position in SPDR S&P Biotech ETF during the second quarter valued at $32,000. Davis Capital Management purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $35,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at $40,000.
SPDR S&P Biotech ETF Stock Performance
Shares of NYSEARCA XBI opened at $121.83 on Friday. The company has a market cap of $8.14 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 52-week low of $66.66 and a 52-week high of $132.09. The firm’s fifty day moving average is $125.47 and its two-hundred day moving average is $115.18.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
